↓ Skip to main content

Dove Medical Press

Ovo Like Zinc Finger 2 (OVOL2) Suppresses Breast Cancer Stem Cell Traits and Correlates with Immune Cells Infiltration

Overview of attention for article published in Breast cancer targets and therapy, August 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

blogs
1 blog
twitter
3 X users

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
9 Mendeley
Title
Ovo Like Zinc Finger 2 (OVOL2) Suppresses Breast Cancer Stem Cell Traits and Correlates with Immune Cells Infiltration
Published in
Breast cancer targets and therapy, August 2022
DOI 10.2147/bctt.s363114
Pubmed ID
Authors

Jiafa Wu, Dongping Luo, Shengnan Li

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 9 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 1 11%
Student > Ph. D. Student 1 11%
Professor > Associate Professor 1 11%
Researcher 1 11%
Student > Master 1 11%
Other 0 0%
Unknown 4 44%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 2 22%
Unspecified 1 11%
Pharmacology, Toxicology and Pharmaceutical Science 1 11%
Agricultural and Biological Sciences 1 11%
Unknown 4 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 August 2022.
All research outputs
#4,413,586
of 26,169,168 outputs
Outputs from Breast cancer targets and therapy
#61
of 329 outputs
Outputs of similar age
#84,823
of 437,242 outputs
Outputs of similar age from Breast cancer targets and therapy
#1
of 9 outputs
Altmetric has tracked 26,169,168 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 329 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.3. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 437,242 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them